| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 19, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - SHIRE PLC (SHP-LN) | 11 | $25 | | May 15, 2013 | Streetwise Reports | N/A | Two Biotech Ideas You May Have Missed: William Gregozeski | 7 | $57.50 | | May 14, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Shire PLC | 42 | $483 | | May 10, 2013 | Reuters Investment Profile | N/A | Shire PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | | May 9, 2013 | Streetwise Reports | Jason Kolbert | Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert | 10 | $92 | | May 1, 2013 | Thomson Reuters StreetEvents | Research Department | SHP.L - Event Transcript of Shire PLC conference call, May 02, 2013 / 8:00AM ET | 17 | $75 | | May 1, 2013 | Thomson Reuters StreetEvents | Research Department | SHP.L - Event Brief of Shire PLC conference call, May 02, 2013 / 8:00AM ET | 18 | $75 | | Apr 30, 2013 | GlobalData | GlobalData | Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review | 56 | $125 | | Apr 15, 2013 | Streetwise Reports | N/A | What Will It Take for Stem Cell Companies to Close the Valuation Gap?: ARM's Chairman Geoff MacKay | 6 | $46 |
|
View All Reports for SHP.L ... |
|
|
36.00(1.76%) 11:35AM EDT